Testing Standards
This page explains how Pexrit Labs describes and publishes laboratory evidence so that testing claims stay aligned with the actual reports.
Current Analytical Scope
The current public Vanguard Laboratory reports for the seven listed 10MG samples document:
- Chromatographic purity by HPLC-UV/VIS
- Measured quantity by HPLC-UV/VIS
- Laboratory ID
- Lot number shown on the submitted report
- Date reported
Current Inventory Lot Matching
Pexrit Labs confirms that the current vials are labeled with the same lot numbers shown on the corresponding reports. This is a Pexrit Labs inventory and labeling confirmation and does not expand the analytical scope of the laboratory reports.
Current Report Results
| Product / tested strength | Laboratory ID | Lot on report | Chromatographic purity | Measured quantity |
|---|---|---|---|---|
| Tirzepatide 10MG | V260601-26 001 | PX-TIRZ-250526-01 | >99.80% + 0.18% | 10.70 mg |
| Retatrutide 10MG | V260601-26 002 | PX-RETA-250526-01 | 98.86% + 0.18% | 11.74 mg |
| Semaglutide 10MG | V260601-26 003 | PX-SEMA-250526-01 | 99.11% + 0.18% | 10.30 mg |
| BPC-157 10MG | V260601-26 004 | PX-BPC157-250526-01 | >99.80% + 0.18% | 11.09 mg |
| TB-500 10MG | V260601-26 005 | PX-TB500-250526-01 | >99.80% + 0.18% | 10.95 mg |
| Ipamorelin 10MG | V260601-26 006 | PX-IPA-250526-01 | 97.55% + 0.18% | 10.13 mg |
| Tesamorelin 10MG | V260601-26 007 | PX-TESA-250526-01 | 99.05% + 0.18% | 10.74 mg |
No Implied Testing
Pexrit Labs does not treat a purity/quantity report as evidence of identity, sterility, endotoxin, microbiological, or other testing unless that analysis is explicitly listed on the report itself.
Sample and Lot Limitations
The Vanguard Laboratory reports state that results relate only to the tested portion of the sample and that the laboratory did not observe or participate in sample selection. The reports further state that the laboratory cannot confirm the authenticity of the sample or its representativeness of the associated lot or batch.
Pexrit Labs' current-lot statement above is therefore a merchant inventory and labeling statement, not an expansion of what Vanguard independently verified.
Strength-Specific Reports
Where Pexrit Labs sells more than one strength of a product, a report for one strength is not presented as evidence of the quantity of another strength. At present, the public Tirzepatide and Retatrutide reports correspond to 10MG tested samples; separate public reports for their larger listed strengths are not currently published.
Research Use Only
Products are intended solely for laboratory research and in vitro testing and are not intended for human or animal use.